Page last updated: 2024-08-05 11:06:44

piperidine alkaloid

null

ChEBI ID: 26147

Members (9)

MemberDefinitionRole
1-deoxynojirimycinAn optically active form of 2-(hydroxymethyl)piperidine-3,4,5-triol having 2R,3R,4R,5S-configuration.duvoglustat
ammodendrineA piperidine alkaloid that is piperidine substituted by a 1-acetyl-1,4,5,6-tetrahydropyridin-3-yl group at position 2 (the 2R-stereoisomer).ammodendrine
anabasineA pyridine alkaloid that is pyridine substituted by a piperidin-2-yl group at position 3.anabasine
himbacineA piperidine alkaloid that is decahydronaphtho[2,3-c]furan-1(3H)-one substituted by a methyl group at position 3 and a 2-[(2R,6S)-1,6-dimethylpiperidin-2-yl]ethenyl group at position 4. It has been isolated from the bark of Australian magnolias.himbacine
lobelineAn optically active piperidine alkaloid having a 2-oxo-2-phenylethyl substituent at the 2-position and a 2-hydroxy-2-phenylethyl group at the 6-position.(-)-lobeline
mor-14A hydroxypiperidine that is duvoglustat in which the amino hydrogen is replaced by a methyl group. It is an inhibitor of alpha-glucosidase, an agonist of the glucose sensor SGLT3 and exhibits anti-HIV activity.N-methyl-1-deoxynojirimycin
piperineA N-acylpiperidine that is piperidine substituted by a (1E,3E)-1-(1,3-benzodioxol-5-yl)-5-oxopenta-1,3-dien-5-yl group at the nitrogen atom. It is an alkaloid isolated from the plant Piper nigrum.piperine
stenusinA member of the class of piperidines that is piperidine substituted by ethyl and 2-methylbutyl groups at positions 1 and 3, respectively.1-ethyl-3-(2-methylbutyl)piperidine
veratramineA piperidine alkaloid comprising the 14,15,16,17-tetradehydro derivative of veratraman having two hydroxy groups at the 3- and 23-positions.veratramine

Research

Studies (2,570)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-1990238 (9.26)18.7374
1990's398 (15.49)18.2507
2000's589 (22.92)29.6817
2010's962 (37.43)24.3611
2020's383 (14.90)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials180 (6.66%)5.53%
Reviews188 (6.95%)6.00%
Case Studies55 (2.03%)4.05%
Observational10 (0.37%)0.25%
Other2,271 (83.99%)84.16%